Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FCFDQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,877
Award facts
- Contract value 100% obligated
- $8,876.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pens with a ceiling value of $8,876.62. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive set-aside procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical vendor for federal medical procurement through numerous competitively awarded contracts with the Defense Logistics Agency. The company supplies a diverse portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Wegovy, a GLP-1 receptor agonist used for weight management, represents another addition to the company's extensive delivery order portfolio under its DLA prime contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FCFDQ?
SPE2DB25FCFDQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FCFDQ worth?
The government has obligated $8,877 on SPE2DB25FCFDQ.
Is contract SPE2DB25FCFDQ an order under another contract?
Yes. SPE2DB25FCFDQ is a delivery order under SPE2DB24D1006, an indefinite delivery contract.
Was contract SPE2DB25FCFDQ competed?
The extent of competition for SPE2DB25FCFDQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award